We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Surgical Innovations Group Plc | LSE:SUN | London | Ordinary Share | GB0004016704 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.60 | 0.50 | 0.50 | 0.50 | 501,471 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 11.34M | 264k | 0.0003 | 16.67 | 4.66M |
TIDMSUN
RNS Number : 3498C
Surgical Innovations Group PLC
27 June 2016
Surgical Innovations Group plc
(the "Company")
Issue of Shares
The Company has issued and allotted a total of 905,660 ordinary shares of 1p each ("Shares") at a price of 1.7 pence per share to Nigel Rogers, Executive Chairman, and Michael McMahon, Paul Hardy and Alistair Taylor, Non-Executive Directors.
Details of the Shares issued and the resulting holdings of each of the directors are as follows:
Director Shares issued Resulting Percentage holding of enlarged share capital Nigel Rogers 258,600 3,163,873 0.65% Michael McMahon 176,471 17,959,366 3.68% Paul Hardy * 294,118 3,208,091 0.66% Alistair Taylor 176,471 390,199 0.08%
* Paul Hardy's beneficial holding comprises the holdings of Hardy Transaction Management Limited, a company in which he has a controlling interest, and his SIPP
As the Shares have been issued in lieu of remuneration for the second quarter of 2016, the issue price was set at the closing price on the date of the Company's payroll in June.
Application will be made for 905,660 Shares to be admitted to trading on AIM ("Admission") which is expected to take place on 1 July 2016.
Following Admission, the total number of ordinary shares in issue will be 487,993,014 with each share carrying the right to one vote. The above figure may be used by shareholders as the denominator for the purposes of the Disclosure and Transparency Rules.
ENDS
For further information please visit www.sigroupplc.com or contact:
Enquiries:
For further information please contact:
Surgical Innovations Group Plc www.sigroupplc.com Nigel Rogers, Executive Chairman Tel: 0113 230 7597 Melanie Ross, Group FD & Managing Director, SI Ltd WH Ireland Limited (NOMAD & Tel: 0113 394 6600 Broker) Tim Feather/Liam Gribben Walbrook PR (Financial PR & Tel: 020 7933 8780 Investor Relations) or si@walbrookpr.com Paul McManus Mob: 07980 541 893 Natalie Bruce Mob: 07884 666 994
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEBDLFLQQFLBBQ
(END) Dow Jones Newswires
June 27, 2016 06:29 ET (10:29 GMT)
1 Year Surgical Innovations Chart |
1 Month Surgical Innovations Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions